Risk Factors for Pulmonary Embolism in Individuals Infected with SARS-CoV2-A Single-Centre Retrospective Study

被引:0
作者
Herlo, Alexandra [1 ]
Marinescu, Adelina Raluca [1 ]
Cut, Talida Georgiana [1 ]
Laza, Ruxandra [1 ]
Oancea, Cristian Iulian [2 ,3 ]
Manolescu, Diana [4 ]
Hogea, Elena [5 ]
Porosnicu, Tamara Mirela [6 ,7 ]
Sincaru, Suzana Vasilica [8 ]
Dumache, Raluca [9 ]
Ispas, Sorina [10 ]
Twakor, Andreea Nelson [11 ]
Nicolae, Maria [12 ]
Lazureanu, Voichita Elena [1 ]
机构
[1] Victor Babes Univ Med & Pharm Timisoara, Dept 13, Discipline Infect Dis, 2 Eftimie Murgu Sq, Timisoara 300041, Romania
[2] Victor Babes Univ Med & Pharm Timisoara, Dept 13, Discipline Pneumol, E Murgu Sq 2, Timisoara 300041, Romania
[3] Victor Babes Univ Med & Pharm Timisoara, Ctr Res & Innovat Precis Med Resp Dis CRIPMRD, E Murgu Sq 2, Timisoara 300041, Romania
[4] Victor Babes Univ Med & Pharm Timisoara, Dept 15, Discipline Radiol, E Murgu Sq 2, Timisoara 300041, Romania
[5] Victor Babes Univ Med & Pharm Timisoara, Dept 14, Discipline Microbiol, E Murgu Sq 2, Timisoara 300041, Romania
[6] Victor Babes Univ Med & Pharm Timisoara, Doctoral Sch, Timisoara 300041, Romania
[7] Victor Babes Clin Hosp Infect Dis & Pneumol, Intens Care Unit, Timisoara 300041, Romania
[8] Emergency Inst Cardiovasc Dis & Transplant, Str Gheorghe Maricescu, Targu Mures 540327, Romania
[9] Victor Babes Univ Med & Pharm, Dept Forens Med Bioeth Med Eth & Med Law, Timisoara 300041, Romania
[10] Ovidius Univ, Fac Gen Med, Dept Anat, Constanta 900470, Romania
[11] Cty Clin Emergency Hosp Constanta, Dept Internal Med, Constanta 900591, Romania
[12] Cty Clin Emergency Hosp Constanta, Dept Pediat, Constanta 900591, Romania
关键词
COVID-19; SARS-CoV-2; thrombosis; mortality; pulmonary embolism; VENOUS THROMBOEMBOLISM; MICROPARTICLES; HYPERTENSION; DISPARITIES; PREVENTION; MANAGEMENT; THROMBOSIS;
D O I
10.3390/biomedicines12040774
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The emergence of SARS-CoV2 has presented itself as a significant global health crisis. The prevalence of thrombotic events is known to be high in these patients, affecting various organ systems, sometimes leading to cutaneous thrombosis, pulmonary embolism (PE), stroke, or coronary thrombosis. The available evidence suggests that thromboembolism, hypercoagulability, and the excessive production of proinflammatory cytokines play a significant role in the development of multiorgan failure. Methodology: This retrospective single-centre study was conducted at "Victor Babes" University of Medicine and Pharmacy from Timisoara, Romania, involving a total of 420 patients diagnosed with COVID-19. We separated them into a CONTROL group that included 319 patients, and an intervention group (PE) with 101 patients that, subsequent to infection with the virus, developed pulmonary embolism. The study included the reporting of demographic data, laboratory findings, and comorbidities. Results: Out of a total of 420 patients, 24% experienced pulmonary embolism, while 21.42% died. Arterial thrombotic events were found to be associated with factors such as age, cardiovascular disease, levels of white blood cells, D-dimers, and albumin in the blood. The findings of the study indicate that there is an independent association between pulmonary thrombosis and hypertension (odds ratio (OR): 1.1; 95% confidence interval (CI): 0.7 to 1.7; p = 0.6463), cancer (OR: 1.1; 95% CI: 0.6 to 2.3; p = 0.6014), and COPD (OR: 1.2; 95% CI: 0.6 to 2.3; p = 0.4927). On the other hand, there is a stronger correlation between PE and obesity (OR: 2.8; 95% CI: 1.7 to 4.6; p < 0.0001), diabetes (OR: 3.3; 95% CI: 2 to 5.3; p < 0.0001), and dyslipidemia (OR: 3.6; 95% CI: 2.3 to 5.8; p < 0.0001) in a multivariable regression logistic model. Conclusions: Patients diagnosed with severe forms of COVID-19 display a comparable incidence of arterial thrombotic events, which have been linked to poor survival rates.
引用
收藏
页数:23
相关论文
共 72 条
[61]  
Ross S.M., 2010, eBooks, DOI [10.1016/b978-0-12-374388-6.00004-1, DOI 10.1016/B978-0-12-374388-6.00004-1]
[62]   Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review [J].
Sakr, Yasser ;
Giovini, Manuela ;
Leone, Marc ;
Pizzilli, Giacinto ;
Kortgen, Andreas ;
Bauer, Michael ;
Tonetti, Tommaso ;
Duclos, Gary ;
Zieleskiewicz, Laurent ;
Buschbeck, Samuel ;
Ranieri, V. Marco ;
Antonucci, Elio .
ANNALS OF INTENSIVE CARE, 2020, 10 (01)
[63]   Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis [J].
Saluk-Bijak, Joanna ;
Dziedzic, Angela ;
Bijak, Michal .
CELLS, 2019, 8 (02)
[64]  
Senst B, 2023, StatPearls
[65]   Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies [J].
Serdar, Ceyhan Ceran ;
Cihan, Murat ;
Yucel, Dogan ;
Serdar, Muhittin A. .
BIOCHEMIA MEDICA, 2021, 31 (01) :1-27
[66]   Emerging Concepts in Immune Thrombocytopenia [J].
Swinkels, Maurice ;
Rijkers, Maaike ;
Voorberg, Jan ;
Vidarsson, Gestur ;
Leebeek, Frank W. G. ;
Jansen, A. J. Gerard .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[67]   Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis [J].
Tan, Boun Kim ;
Mainbourg, Sabine ;
Friggeri, Arnaud ;
Bertoletti, Laurent ;
Douplat, Marion ;
Dargaud, Yesim ;
Grange, Claire ;
Lobbes, Herve ;
Provencher, Steeve ;
Lega, Jean-Christophe .
THORAX, 2021, 76 (10) :970-979
[68]  
The Romanian National Institute of Public Health, About us
[69]   Factors Influencing the Evolution of Pulmonary Hypertension in Previously Healthy Subjects Recovering from a SARS-CoV-2 Infection [J].
Tudoran, Cristina ;
Tudoran, Mariana ;
Lazureanu, Voichita Elena ;
Marinescu, Adelina Raluca ;
Cut, Talida Georgiana ;
Oancea, Cristian ;
Pescariu, Silvius Alexandru ;
Pop, Gheorghe Nicusor .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
[70]  
World Health Organization, 2023, Therapeutics and COVID-19: Living Guideline